Skip to main content
. Author manuscript; available in PMC: 2014 Dec 9.
Published in final edited form as: Nature. 2014 Feb 5;507(7491):201–206. doi: 10.1038/nature12966

Table 1.

Biophysical properties of scaffolds and scaffold-antibody interactions. ND, not done.

Molecule Multimeric State Tm
(°C)
ΔG (kcal mol-1) SPR Motavizumab NMR-HSQC Dispersion
kon (M-1s-1) koff (s-1) koff/kon (pM)
FFL_001 Mon 76 ND 3.99 × 106 1.19 × 10-4 29.9 Dispersed
FFL_002 Mon 49 ND 1.56 × 106 7.34 × 10-4 469.9 ND
FFL_004 Mon >85 ND 1.05 × 106 8.32 × 10-4 795.0 ND
FFL_005 Mon >100 15.0 2.97 × 106 2.09 × 10-4 70.3 Partially Dispersed
FFL_006 Mon >85 ND 3.57 × 106 2.32 × 10-4 651.9 Dispersed
FFL_007 Mon >85 ND 1.45 × 106 1.36 × 10-4 94.1 Partially Dispersed
FFL_001_surf1 Mon 84 8.2 7.43 × 106 4.70 × 10-4 6.32 ND
FFL_001_surf2 Mon >85 8.1 5.32 × 106 1.58 × 10-4 29.6 ND
FFL_001_surf4 Mon >85 9.0 4.80×106 1.58 × 10-4 32.9 ND
HHS Vulnerability Disclosure